298 related articles for article (PubMed ID: 22737146)
1. Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.
Hoshino H
Front Microbiol; 2012; 3():222. PubMed ID: 22737146
[TBL] [Abstract][Full Text] [Related]
2. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
3. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
4. Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Maeda Y; Terasawa H; Tanaka Y; Mitsuura C; Nakashima K; Yusa K; Harada S
J Virol; 2015 Jan; 89(1):502-11. PubMed ID: 25339765
[TBL] [Abstract][Full Text] [Related]
5. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
6. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
8. In vitro cellular tropism of human T cell leukemia virus type 2.
Wang TG; Ye J; Lairmore MD; Green PL
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1661-8. PubMed ID: 11080807
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
Jones KS; Petrow-Sadowski C; Bertolette DC; Huang Y; Ruscetti FW
J Virol; 2005 Oct; 79(20):12692-702. PubMed ID: 16188972
[TBL] [Abstract][Full Text] [Related]
10. HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?
Manel N; Taylor N; Kinet S; Kim FJ; Swainson L; Lavanya M; Battini JL; Sitbon M
Front Biosci; 2004 Sep; 9():3218-41. PubMed ID: 15353351
[TBL] [Abstract][Full Text] [Related]
11. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.
Gessain A; Gout O; Saal F; Daniel MT; Rio B; Flandrin G; Sigaux F; Lyon-Caen O; Periès J; de-Thé G
Cancer Res; 1990 Sep; 50(17 Suppl):5692S-5696S. PubMed ID: 2201441
[TBL] [Abstract][Full Text] [Related]
15. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
[TBL] [Abstract][Full Text] [Related]
16. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
[TBL] [Abstract][Full Text] [Related]
17. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
18. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Tanaka A; Jinno-Oue A; Shimizu N; Hoque A; Mori T; Islam S; Nakatani Y; Shinagawa M; Hoshino H
J Virol; 2012 Mar; 86(6):2959-69. PubMed ID: 22238310
[TBL] [Abstract][Full Text] [Related]
19. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
[TBL] [Abstract][Full Text] [Related]
20. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
